LncRNA SNHG12 promotes proliferation and epithelial mesenchymal transition in hepatocellular carcinoma through targeting HEG1 via miR-516a-5p

Yang, 2019, A global view of hepatocellular carcinoma: trends, risk, prevention and management, Nat. Rev. Gastroenterol. Hepatol., 16, 589, 10.1038/s41575-019-0186-y Allemani, 2018, Global surveillance of trends in cancer survival 2000–14 (CONCORD-3): analysis of individual records for 37513025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries, Lancet, 391, 1023, 10.1016/S0140-6736(17)33326-3 Sun, 2016, Liver cancer stem cell markers: progression and therapeutic implications, World J. Gastroenterol., 22, 3547, 10.3748/wjg.v22.i13.3547 Li, 2016, Heterogeneity of liver cancer and personalized therapy, Cancer Lett., 379, 191, 10.1016/j.canlet.2015.07.018 Sia, 2017, Liver cancer cell of origin, molecular class, and effects on patient prognosis, Gastroenterology, 152, 745, 10.1053/j.gastro.2016.11.048 Qi, 2015, ceRNA in cancer: possible functions and clinical implications, J. Med. Genet., 52, 710, 10.1136/jmedgenet-2015-103334 Zhang, 2016, Comprehensive characterization of lncRNA-mRNA related ceRNA network across 12 major cancers, Oncotarget, 7, 10.18632/oncotarget.11637 Tamang, 2019, SNHG12: an LncRNA as a potential therapeutic target and biomarker for human Cancer, Front. Oncol., 9, 901, 10.3389/fonc.2019.00901 Zhou, 2018, LncRNA SNHG12 promotes tumorigenesis and metastasis in osteosarcoma by upregulating Notch2 by sponging miR-195-5p, Biochem. Biophys. Res. Commun., 495, 1822, 10.1016/j.bbrc.2017.12.047 Wang, 2017, LncRNA SNHG12 promotes cell growth and inhibits cell apoptosis in colorectal cancer cells, Braz. J. Med. Biol. Res., 50, 10.1590/1414-431x20176079 Yang, 2018, LncRNA SNHG12 regulated the proliferation of gastric carcinoma cell BGC-823 by targeting microRNA-199a/b-5p, Eur. Rev. Med. Pharmacol. Sci., 22, 1297 Zhang, 2018, LncRNA SNHG12 regulates gastric cancer progression by acting as a molecular sponge of miR-320, Mol. Med. Rep., 17, 2743 Lan, 2017, Long non-coding RNA small nucleolar RNA host gene 12 (SNHG12) promotes tumorigenesis and metastasis by targeting miR-199a/b-5p in hepatocellular carcinoma, J. Exp. Clin. Cancer Res., 36, 11, 10.1186/s13046-016-0486-9 Chatterjee, 2017, Biological networks in Parkinson's disease: an insight into the epigenetic mechanisms associated with this disease, BMC Genomics, 18, 721, 10.1186/s12864-017-4098-3 Wang, 2018, Long non-coding RNAs, novel culprits, or bodyguards in neurodegenerative diseases, Mol. Ther. Nucleic Acids, 10, 269, 10.1016/j.omtn.2017.12.011 Mishra, 2016, Exploring miRNA based approaches in cancer diagnostics and therapeutics, Crit. Rev. Oncol. Hematol., 98, 12, 10.1016/j.critrevonc.2015.10.003 Bernardo, 2015, miRNA therapeutics: a new class of drugs with potential therapeutic applications in the heart, Future Med. Chem., 7, 1771, 10.4155/fmc.15.107 Title, 2018, Genetic dissection of the miR-200-Zeb1 axis reveals its importance in tumor differentiation and invasion, Nat. Commun., 9, 4671, 10.1038/s41467-018-07130-z Ma, 2010, miR-9, a MYC/MYCN-activated microRNA, regulates E-cadherin and cancer metastasis, Nat. Cell Biol., 12, 247, 10.1038/ncb2024 Kim, 2011, A p53/miRNA-34 axis regulates Snail1-dependent cancer cell epithelial-mesenchymal transition, J. Cell Biol., 195, 417, 10.1083/jcb.201103097 Rokavec, 2014, IL-6R/STAT3/miR-34a feedback loop promotes EMT-mediated colorectal cancer invasion and metastasis, J. Clin. Invest., 124, 1853, 10.1172/JCI73531 Chi, 2019, miR-516a-3p inhibits breast cancer cell growth and EMT by blocking the Pygo2/Wnt signalling pathway, J. Cell. Mol. Med., 23, 6295, 10.1111/jcmm.14515 Ye, 2019, MiR-516a-5p inhibits the proliferation of non-small cell lung cancer by targeting HIST3H2A, Int. J. Immunopathol. Pharmacol., 33, 10.1177/2058738419841481 Yao, 2019, Circ_0001955 facilitates hepatocellular carcinoma (HCC) tumorigenesis by sponging miR-516a-5p to release TRAF6 and MAPK11, Cell Death Dis., 10, 945, 10.1038/s41419-019-2176-y Pastushenko, 2019, EMT transition states during tumor progression and metastasis, Trends Cell Biol., 29, 212, 10.1016/j.tcb.2018.12.001 Giannelli, 2016, Role of epithelial to mesenchymal transition in hepatocellular carcinoma, J. Hepatol., 65, 798, 10.1016/j.jhep.2016.05.007 Zhao, 2019, HEG1 indicates poor prognosis and promotes hepatocellular carcinoma invasion, metastasis, and EMT by activating Wnt/β-catenin signaling, Clin. Sci. (Lond.), 133, 1645, 10.1042/CS20190225 Zhao, 2018, SNHG12 promotes angiogenesis following ischemic stroke via regulating miR-150/VEGF pathway, Neuroscience, 390, 231, 10.1016/j.neuroscience.2018.08.029 Zhou, 2018, Long noncoding RNA SNHG12 mediates doxorubicin resistance of osteosarcoma via miR-320a/MCL1 axis, Biomed. Pharmacother., 106, 850, 10.1016/j.biopha.2018.07.003 Smillie, 2018, Complexities of post-transcriptional regulation and the modeling of ceRNA crosstalk, Crit. Rev. Biochem. Mol. Biol., 53, 231, 10.1080/10409238.2018.1447542 Joshi, 2016, Integrative analysis of miRNA and gene expression reveals regulatory networks in tamoxifen-resistant breast cancer, Oncotarget, 7, 57239, 10.18632/oncotarget.11136